Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fluctuations of mood and psychic activation were assessed in relation to "mobile" and "immobile" periods in 18 patients with
Parkinson's disease
presenting typical "end-of-dose deterioration". Twelve subjects with chronic but active rheumatoid arthritis presenting increased physical disability due to severe morning
joint stiffness
with a repetitive pattern of mobile and immobile periods acted as controls. The overall degree of disability and its fluctuations were close enough in the two groups for fair comparison of changes in affective behaviour. Temporary immobility was accompanied by adverse changes of mood and activation, which were significantly more marked in the
Parkinson's disease
group than in the controls, though to a lesser extent in those
Parkinson's disease
patients rated depressed even in their mobile periods. The possible correlation between mood changes and fluctuations of central dopaminergic function in the
Parkinson's disease
patients is discussed.
...
PMID:Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. 378 80
This work presents a framework for computing the limbs' stiffness using inverse methods that account for the musculoskeletal redundancy effects. The musculoskeletal task, joint and muscle stiffness are regulated by the central nervous system towards improving stability and interaction with the environment during movement. Many pathological conditions, such as
Parkinson's disease
, result in increased rigidity due to elevated muscle tone in antagonist muscle pairs, therefore the stiffness is an important quantity that can provide valuable information during the analysis phase. Musculoskeletal redundancy poses significant challenges in obtaining accurate stiffness results without introducing critical modeling assumptions. Currently, model-based estimation of stiffness relies on some objective criterion to deal with muscle redundancy, which, however, cannot be assumed to hold in every context. To alleviate this source of error, our approach explores the entire space of possible solutions that satisfy the action and the physiological muscle constraints. Using the notion of null space, the proposed framework rigorously accounts for the effect of muscle redundancy in the computation of the feasible stiffness characteristics. To confirm this, comprehensive case studies on hand movement and gait are provided, where the feasible endpoint and
joint stiffness
is evaluated. Notably, this process enables the estimation of stiffness distribution over the range of motion and aids in further investigation of factors affecting the capacity of the system to modulate its stiffness. Such knowledge can significantly improve modeling by providing a holistic overview of dynamic quantities related to the human musculoskeletal system, despite its inherent redundancy.
...
PMID:Stiffness modulation of redundant musculoskeletal systems. 3070 54